 |
 |
 |
Home: News
Room: Stories: The
Unsung Heroes of Tuberculosis Control
The Unsung Heroes of Tuberculosis Control
MSH works with the Global Drug Facility
to help laboratory staff in Congo-Brazzaville improve tuberculosis
detection

Tuberculosis (TB)
is a public health emergency: 8 million people worldwide develop
active TB each year. Diagnosing patients with TB, by examining
their sputum under the microscope to detect tuberculosis bacteria,
is pivotal to the control of this disease. This relatively simple,
but labor-intensive laboratory test requires great concentration
and attention to detail. It can be tedious even in the best-equipped
laboratories, but is much more difficult for staff in resource-poor
countries, where basic equipment and materials are often lacking.
This is the case in Congo-Brazzaville, a country in central Africa
with high rates of TB, where the three-year civil war between 1997
and 1999 disrupted the activities of the national TB program and
destroyed 80% of laboratory resources.
Despite the harsh conditions, laboratory staff
in the two major cities, Brazzaville and Pointe-Noire, have been
seeking creative ways to keep their laboratory services running.
For example, when they ran out of sputum collection containers
for patients to provide specimens, technicians enlisted the help
of local photo shops to supply them with film canisters to serve
that purpose. When the electricity needed to power the microscopes
goes out during the daytime, they often return to the laboratory
at night when the power comes back on, to read the slides and provide
test results as quickly as possible. These motivated laboratory
technicians, working behind the scenes to ensure that patients
are diagnosed in a timely manner, are indeed among the "unsung
heroes" of TB control.
The Global
TB Drug Facility (GDF) and Management Sciences for Health
(MSH) are experimenting with the development of diagnostic laboratory
kits for use in resource-poor countries with high rates of TB.
Over the last year, they have been working together to design
standardized "test kits" containing all the essential items needed
for sputum microscopy: good microscopes with rechargeable backup
batteries, disposable sputum collection cups, and stains and
reagents to prepare the smears, as well as other basic laboratory
equipment. Congo-Brazzaville is the first country to receive
these kits for evaluation. They are also being tested in Nigeria
and Tajikistan.
Most cases of TB are curable by treatment with
standardized drug regimens. Until recently one of the major barriers
to TB control was the lack of appropriate low-cost TB drugs. Since
2001, the GDF and its partners have been providing these to many
countries worldwide, including Congo-Brazzaville. With MSH's assistance,
the GDF is now looking to expand its activities to address the
challenge of providing high-quality diagnostic services. If successful
in the trial tests, the new laboratory kits will also be made available
worldwide. Appropriate laboratory supplies and equipment are critical
resources for laboratories to provide the accurate diagnoses required
to start patients on TB drug therapy and to monitor their progress
during treatment.
|